Monoamine dysfunction and the pathophysiology and treatment of depression

Keyphrases

• Pathophysiology 100%
• Monoamines 100%
• Antidepressants 100%
• Depression Treatment 100%
• Selective Serotonin Reuptake Inhibitors 100%
• Serotonergic 100%
• Noradrenergic 100%
• Serotonin-norepinephrine Reuptake Inhibitors 100%
• Tryptophan 66%
• Remission 66%
• Central Nervous System 66%
• Depressed Patients 66%
• Drag-free 66%
• Behavioral Effects 33%
• Mechanism of Action 33%
• Therapeutic Response 33%
• Catecholamines 33%
• Amino Acids 33%
• Differential Response 33%
• Plasma Parameters 33%
• Tryptophan Depletion 33%
• Depressed Mood 33%
• Desipramine 33%
• Neurotransmission 33%
• Neural Systems 33%
• Serum Serotonin 33%
• Brain Monoamines 33%
• Serotonin Metabolism 33%
• Free Amino Acids 33%
• Catecholamine System 33%

Neuroscience

• Monoamine 100%
• Treatment of Depression 100%
• Serotonergic 100%
• Tryptophan 100%
• Antidepressant 66%
• Central Nervous System 66%
• Serotonin 66%
• Catecholamine 66%
• Selective Serotonin Reuptake Inhibitor 66%
• Norepinephrine 66%
• Norepinephrine Reuptake Inhibitor 66%
• Behavioral Effect 33%
• Metabolic Pathway 33%
• Amino Acid 33%
• Antidepressant 33%
• Synaptic Transmission 33%
• Serotonin-Norepinephrine Reuptake Inhibitor 33%
• Neural System 33%
• Brain Monoamine 33%
• Desipramine 33%
• alpha methyl p tyrosine 33%
• Essential Amino Acid 33%
• Blood Plasma 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Pathophysiology 100%
• Monoamine 100%
• Tryptophan 100%
• Remission 66%
• Antidepressant 66%
• Catecholamine 66%
• Serotonin 66%
• Noradrenalin 66%
• Selective Serotonin Reuptake Inhibitor 66%
• Norepinephrine Reuptake Inhibitor 66%
• Behavioral Effect 33%
• Amino Acid 33%
• Serotonin-Norepinephrine Reuptake Inhibitor 33%
• Desipramine 33%
• Essential Amino Acid 33%
• Antidepressant 33%
• Brain Monoamine 33%